Dr Heck completed his undergraduate training in medicine at Cambridge University (Gonville and Caius College) in 1997 and later graduated from clinical school at Oxford University in 2000. After completing his junior doctor training, Dr Heck undertook his specialist training in Cardiology in Cambridge before completing a period of post-graduate clinical research for he was awarded a Doctor of Medicine (DM) from Oxford University in 2010. He then completed an 18-month Electrophysiology Fellowship at the Royal Melbourne Hospital, Australia, one of the world’s leading centres in cardiac electrophysiology.

His areas of major interest are ablation of all cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia. Additionally, he is interested in complex device implantation (ICDs and CRT) and is trained in the device extraction.

Specialist Clinical Interests

Arrhythmias, Catheter Ablation, Device Extractions, Atrial Fibrillation, Ventricular Tachycardia, Complex Device Therapy

Research Interests

Atrial Fibrillation, Cardiac Resynchronisation Therapy

Education and Training

BA Mammalian Physiology (Cambridge) 1997
BM BCh (Oxford) 2000
MA (Oxford) 2001
MRCP (UK) 2003
DM (Oxford) 2010

Current membership(s) of professional, national and regional bodies and university posts

Member of the Royal College of Physicians, London.
Member of the General Medical Council (registration number: 4731722).
Member of Heart Rhythm Society
Member of the British Cardiac Society

Recent and Important Publications

Book Chapters
Heck P
, Teh A, Kalman J: How to Ablate Atrial Tachycardias. In Al-Ahmad A, Callans D, Hsia H, Natale A, Oseroff O, Wang P, eds: Hands-On Ablation: The Experts' Approach: Cardiotext Publishing, in press.

Heck P, Fynn S: Cardiac Arrhythmias. In Hobbs R, Mcmanus RJ, Taylor CJ, eds: Cardiovascular Disease in Primary Care: Royal College of General Practitioners, 2011.

Journal Publication

Barra S, Providência R, Boveda S, Duehmke R, Narayanan K, Chow AW, Piot O, Klug D, Defaye P, Gras D, Deharo JC, Milliez P, Da Costa A, Mondoly P, Gonzalez-Panizo J, Leclercq C, Heck P, Virdee M, Sadoul N, Le Heuzey JY, Marijon E. Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention. Heart. 2018 Mar 14. pii: heart jnl-2017-312546.

Barra S, Duehmke R, Providencia R, Marijon E, Boveda S, Virdee M, Heck P, Fynn S, Begley D, Grace A, Agarwal S. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis. Europace. 2018 Jan 1;20(1):89-96.

Sertic F, Bosco P, Ferrara A, Heck P, Abu-Omar Y. ICD lead extraction: Not a benign procedure. External chest compression: Not a benign manoeuvre. JRSM Cardiovasc Dis. 2017 Sep 12;6:2048004017731040.

Martin CA, Curtain JP, Gajendragadkar PR, Begley DA, Fynn SP, Grace AA, Heck PM, Salaunkey K, Virdee MS, Agarwal S. Improved outcome and cost effectiveness in ablation of persistent atrial fibrillation under general anaesthetic. Europace. 2017 Apr 21.

Barra S, Goonewardene M, Heck P, Begley D, Virdee M, Fynn S, Grace A, Agarwal S. Implantable cardioverter-defibrillator elective generator replacement: a procedure for all? J Interv Card Electrophysiol. 2016 Mar;45(2):209-18.

Barra S, Providência R, Tang A, Heck P, Virdee M, Agarwal S. Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2015 Nov 6;4(11). pii: e002539.

McCormick LM, Heck PM, Ring LS, Kydd AC, Clarke SJ, Hoole SP, Dutka DP. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus. Cardiovasc Diabetol. 2015 Aug 8;14:102.

McLellan AJ, Ling LH, Azzopardi S, Lee GA, Lee G, Kumar S, Wong MC, Walters TE, Lee JM, Looi KL, Halloran K, Stiles MK, Lever NA, Fynn SP, Heck PM, Sanders P, Morton JB, Kalman JM, Kistler PM. A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomized controlled trial (the Minimax study). Eur Heart J. 2015 Jul 21;36(28):1812-21

Barra S, Begley D, Heck P, Turner I, Agarwal S. Ablation of ventricular tachycardia in the very elderly patient with cardiomyopathy: how old is too old? Can J Cardiol. 2015 Jun;31(6):717-22.

Goonewardene M, Barra S, Heck P, Begley D, Fynn S, Virdee M, Grace A, Agarwal S. Cardioverter-defibrillator implantation and generator replacement in the octogenarian. Europace. 2015 Mar;17(3):409-16.

Barra S, Providência R, Paiva L, Heck P, Agarwal S. Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Europace. 2015 Feb;17(2):174-86.

 Kumar S, Brown G, Sutherland F, Morgan J, Andrews D, Ling LH, McLELLAN AJ, Lee G, Robinson T, Heck P, Halloran K, Morton J, Kistler P, Kalman JM, Sparks PB. The transesophageal echo probe may contribute to esophageal injury after catheter ablation for paroxysmal atrial fibrillation under general anesthesia: a preliminary observation. J Cardiovasc Electrophysiol. 2015 Feb;26(2):119-26.